12
results
for author:"Kerem B."
in Literature Citations
| Impaired replication stress response in cells from immunodeficiency patients carrying Cernunnos/XLF mutations. Schwartz M., Oren Y.S., Bester A.C., Rahat A., Sfez R., Yitzchaik S., de Villartay J.P., Kerem B. PLoS ONE 4:e4516-e4516(2009) · Mapped (1) |
| Interplay between ATM and ATR in the regulation of common fragile site stability. Ozeri-Galai E., Schwartz M., Rahat A., Kerem B. Oncogene 27:2109-2117(2008) · Mapped (9) |
| Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia. Feuk L., Kalervo A., Lipsanen-Nyman M., Skaug J., Nakabayashi K., Finucane B., Hartung D., Innes M., Kerem B., Nowaczyk M.J. et al. Am. J. Hum. Genet. 79:965-972(2006) · Mapped (12) |
| Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation. Nissim-Rafinia M., Aviram M., Randell S.H., Shushi L., Ozeri E., Chiba-Falek O., Eidelman O., Pollard H.B., Yankaskas J.R., Kerem B. EMBO Rep. 5:1071-1077(2004) · Mapped (46) |
| Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. Wilschanski M., Yahav Y., Yaacov Y., Blau H., Bentur L., Rivlin J., Aviram M., Bdolah-Abram T., Bebok Z., Shushi L. et al. N. Engl. J. Med. 349:1433-1441(2003) · Mapped (46) |
| Human chromosome 7: DNA sequence and biology. Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R. et al. Science 300:767-772(2003) · UniProtKB (658) |
| Identification of a new SCN5A mutation, D1840G, associated with the long QT syndrome. Benhorin J., Goldmit M., Maccluer J.W., Blangero J., Goffen R., Leibovitch A., Rahat A., Wang Q., Medina A., Towbin J.A. et al. Hum. Mutat. 12:72-72(1998) · UniProtKB (1) |
| Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits. An R.H., Wang X.L., Kerem B., Benhorin J., Medina A., Goldmit M., Kass R.S. Circ. Res. 83:141-146(1998) · UniProtKB (1) |
| A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations. Kerem E., Rave-Harel N., Augarten A., Madgar I., Nissim-Rafinia M., Yahav Y., Goshen R., Bentur L., Rivlin J., Aviram M. et al. Am. J. Respir. Crit. Care Med. 155:1914-1920(1997) · Mapped (46) |
| Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.-L. et al. |
| Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Kerem B.-S., Zielenski J., Markiewicz D., Bozon D., Gazit E., Yahav J., Kennedy D., Riordan J.R., Collins F.S., Rommens J.M. et al. Proc. Natl. Acad. Sci. U.S.A. 87:8447-8451(1990) · UniProtKB (1) |
| Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Zielenski J., Rozmahel R., Bozon D., Kerem B., Grzelczak Z., Riordan J.R., Rommens J., Tsui L.-C. Genomics 10:214-228(1991) · UniProtKB (1) |
